GNH USA

Europe — EMA

Minulet (Ethinylestradiol, Gestodene)

GNH USA supplies Minulet (Ethinylestradiol / Gestodene), a combined oral contraceptive for preventing pregnancy. Request a quote for global supply today.

Request sourcing

1
Pack/s

What is Ethinylestradiol, Gestodene?

Ethinylestradiol and Gestodene, the active ingredients in Minulet, are a combined oral contraceptive presented as an oral tablet for oral use. It provides hormonal contraception to prevent pregnancy in women of reproductive age. The formulation delivers a fixed dose of estrogen and progestin to regulate the menstrual cycle and suppress ovulation.

GNH USA supplies Minulet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

What is Ethinylestradiol, Gestodene used for?

Minulet, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy. Contraception: Prevents unintended pregnancy in women of childbearing age. Menstrual cycle regulation: Helps achieve more predictable menstrual periods. Acne treatment: Reduces acne lesions associated with hormonal fluctuations. Dysmenorrhea relief: Alleviates painful menstrual cramps. Endometriosis management: Reduces growth of endometrial tissue.

What are the side effects of Ethinylestradiol, Gestodene?

Minulet may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Nausea - Breast tenderness - Headache - Spotting between periods Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Arterial thrombosis (stroke, myocardial infarction) - Severe allergic reaction (anaphylaxis)

What precautions apply to Ethinylestradiol, Gestodene?

Before using Minulet, consider the following precautions. - Smoking: Avoid smoking more than 15 cigarettes per day while taking this product. - Pregnancy: Discontinue use immediately if pregnancy is confirmed; the drug is contraindicated during pregnancy. - Cardiovascular disease: Not recommended for women with a history of thromboembolic disorders or uncontrolled hypertension. - Liver disease: Use with caution in patients with hepatic impairment. - Drug interactions: Review concomitant medications that may affect hormone metabolism. - Store at ambient temperature: Keep tablets below 25 °C in the original pack, protected from moisture and light.

What does Ethinylestradiol, Gestodene interact with?

Minulet can interact with other medicines, altering its effectiveness or safety. Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin) may markedly reduce contraceptive efficacy. - St. John's wort can decrease hormone levels, increasing the risk of unintended pregnancy. Moderate Interactions (Monitor Closely): - Antifungal agents such as ketoconazole may increase plasma concentrations of gestodene. - Certain antiretrovirals (protease inhibitors) can affect hormone metabolism. - Selective serotonin reuptake inhibitors (e.g., fluoxetine) may modestly increase the risk of side effects.

Frequently asked questions

What is Minulet used for?+
Minulet is a combined oral contraceptive containing ethinylestradiol and gestodene. It is prescribed to prevent unintended pregnancy in women of reproductive age and may also be used to regulate menstrual cycles, reduce menstrual pain, and treat hormonally‑related acne. The medication works by suppressing ovulation and creating cervical mucus and endometrial changes that are unfavorable for fertilisation.
How does ethinylestradiol and gestodene work?+
Ethinylestradiol is a synthetic estrogen that provides negative feedback to the hypothalamus‑pituitary axis, while gestodene is a progestin that activates progesterone receptors. Together they inhibit the secretion of LH and FSH, preventing follicular development and ovulation. The hormonal environment also thickens cervical mucus and alters the endometrium, reducing the chance of sperm penetration and implantation.
What is the usual dose of Minulet?+
The dosage regimen for Minulet is determined by the prescribing healthcare professional. Typically, the product is taken as one tablet daily for a 21‑day active phase followed by a hormone‑free interval, but the exact schedule, tablet strength and duration are individualized based on the patient’s medical history and treatment goals. Patients should follow the prescriber’s instructions precisely.
Is Minulet safe during pregnancy or breastfeeding?+
Minulet is contraindicated during pregnancy because it is intended to prevent conception, not to support an existing pregnancy. Women who become pregnant while taking the product should discontinue use and consult a healthcare provider. Regarding breastfeeding, combined oral contraceptives are generally not recommended during lactation, especially in the early postpartum period, due to potential effects on milk production and infant exposure.
How do I order Minulet from GNH USA?+
To request Minulet, visit the product page on gnh-usa.com and submit an enquiry specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams across international markets. After the enquiry, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any necessary import documentation before finalising the order.
How does Minulet compare with other combined oral contraceptives?+
Minulet contains ethinylestradiol paired with gestodene, a third‑generation progestin that is associated with a lower incidence of androgenic side effects such as acne compared with earlier‑generation progestins. Compared with products using levonorgestrel, Minulet may have a slightly different bleeding pattern but offers similar contraceptive efficacy. Choice of product depends on individual risk factors, tolerability and physician preference.
How should Minulet be stored?+
Minulet tablets should be stored at ambient temperature, below 25 °C (77 °F), in the original blister pack or container to protect them from moisture and light. Keep the medication out of reach of children and do not use it after the expiry date printed on the packaging. Avoid storing in bathrooms or other humid environments to maintain product stability.
How is Minulet administered?+
Minulet is taken orally, usually once daily at the same time each day. The typical regimen consists of 21 consecutive active tablets followed by a 7‑day hormone‑free interval, during which withdrawal bleeding occurs. Patients should swallow the tablet whole with water and should not skip or double doses; if a dose is missed, they should follow the guidance provided by their healthcare professional.
What are the most serious risks associated with Minulet?+
The most serious risks of Minulet involve thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke or myocardial infarction, particularly in women who smoke, have hypertension, or possess a personal or family history of clotting disorders. Other rare but severe reactions include severe liver disease, gallbladder disease and life‑threatening allergic reactions. Patients should seek immediate medical attention if they experience unexplained chest pain, severe headache, visual changes or swelling of the limbs.
Who should not use Minulet?+
Minulet is contraindicated in women who are pregnant or breastfeeding, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, known or suspected estrogen‑dependent tumors, or are smokers over 15 cigarettes per day. It should also be avoided in individuals with known hypersensitivity to ethinylestradiol, gestodene or any tablet excipients. Patients with these conditions should discuss alternative contraceptive options with their healthcare provider.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ethinylestradiol, Gestodene
Route
Oral Use
Manufacturer
Pfizer B.V.
Origin
EU

Related products